Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,520
NCT03353922
Driving Simulation to Assess Non-Sedative Effects of Tolperisone
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2017
Completion: Jan 30, 2018
NCT03802565
Tolperisone in Acute Muscle Spasm of the Back
Phase: Phase 2
Start: Feb 1, 2019
Completion: Jul 12, 2019
NCT04407377
Effects of Tolperisone on Measures of Drowsiness and Cognitive Function
Start: Jun 20, 2020
Completion: Mar 31, 2021
NCT04465266
A Phase 1 PK Study of Tolperisone in Healthy Subjects
Start: Jul 28, 2020
Completion: Sep 1, 2021
NCT04671082
Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
Phase: Phase 3
Start: Dec 15, 2020
Completion: Mar 21, 2022